AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 131 min read$RWAY

Runway Growth Provides Q3 2026 Update; $139.4M Portfolio Liquidity, $8.5M Follow‑ons

Runway Growth reported Q3 2026 portfolio updates, including $139.4M in liquidity events and $8.5M in follow-on investments. The company restructured a $28.9M unfunded commitment into a €8.1M bridge loan, funding €5.6M in Q3. As of Sept 30, 2026, the portfolio consists of 52 debt investments and 102 equity investments across 66 companies.

Original reporting
tradingview.com
Published Oct 13, 2026, 12:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 12:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Runway Growth Provides Q3 2026 Update; $139.4M Portfolio Liquidity, $8.5M Follow‑ons — source image
Source · tradingview.com
Decision brief

The 30-second read

$RWAYNeutralLow
01

Why it matters

The 8‑K filing discloses sizable liquidity events and follow‑on funding, offering transparency to shareholders but unlikely to move the stock sharply.

02

Market read

Informational update for investors; minimal immediate trading impact.

03

What to watch

Potential future redeployment of the $139.4M liquidity into new acquisitions.

Relevance 6/10Novelty 6/10Timing: today

Background

Runway Growth Finance Corp (RWAY) is a SPAC that reports portfolio activity in periodic SEC filings.

Company-level read

Ticker impact

$RWAYNeutralHigh confidence
Context

Runway Growth Finance Corp filed an 8‑K reporting $139.4M of liquidity events and $8.5M of follow‑on investments in Q3 2026.

Expected impact

likely little immediate price movement as the information is informational rather than value‑changing

Evidence & confidence

The numbers are new disclosures from the 8‑K, yet they reflect internal portfolio activity that typically has limited direct impact on the market price of the SPAC.

Market effects

Sector

Provides insight into SPAC portfolio trends but no broader sector shift.

Regional

U.S. market only; no regional effect.

Global

Limited to investors tracking SPAC activity.

Counterpoint

What could challenge this read

If the portfolio liquidity indicates successful exits, the SPAC could be undervalued.

Key entities

  • company
    Runway Growth Finance Corp

    SPAC reporting portfolio updates.

Read at source← All news

Related articles

AUG 7
$RWAYMedAI 8/10

Runway Growth Q2 2026 slides: SWK deal drives 71% NII jump

Runway Growth Finance Corp. (RWAY) released Q2 2026 investor slides on Aug. 7, citing the April 6 SWK Holdings acquisition as a driver of results. Net investment income rose 71.7% to $18.2M ($0.43/share). Total investment income rose to $37.0M. NAV per share fell to $11.91 after $8.1M transaction expenses. Shares rose 13.21% to $6.77.

investing.com7 min
AUG 6
$RWAYMed

Runway Growth Finance Corp. Reports Second Quarter 2026 Financial Results

Runway Growth Finance Corp. (RWAY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Runway Growth Finance Corp. Reports Second Quarter 2026 Financial Results Delivered Total and Net Investment Income of $37.0 million and $18.2 million, Respectively Investment Portfolio of $1.2 billion Conference Call on Friday, August 7, 2026 at 10:00 a.m. ET MENLO PARK, Calif.,

SEC EDGAR 8-K7 min
JUL 14
$RWAYMed

Runway Growth Finance Corp. Provides Second Quarter 2026 Business and Portfolio Update

Runway Growth Finance Corp. (Nasdaq: RWAY) reported a Q2 2026 business and portfolio update for the quarter ended June 30, 2026. The company said adviser and affiliates plan to buy up to 10% of outstanding shares if trading remains below 70% of NAV, and it has a $15.0 million repurchase authorization. Q2 funded $85.8 million in new and existing investments and reported $36.5 million in liquidity events.

manilatimes.net6 min
JUL 6
$RWAYMed

Bulldog Investors Calls on Runway Growth Finance Corp. (RWAY) to Expand Its Share Repurchase Program

Bulldog Investors, a >3% shareholder of Runway Growth Finance Corp. (RWAY), urged management to materially expand RWAY’s share repurchase program. It cites RWAY’s May 7 $15m buyback at $6.83 and subsequent decline to $5.49 by July 2, with shares trading ~55% below last reported NAV ($12.13). Bulldog also asks for reduced debt and warns it may nominate directors.

manilatimes.net4 min
JUL 1
$RWAYMed

Is Runway Growth Finance (RWAY) One of the Top 10 Dividend Stocks with 10%+ Yield?

BofA downgraded Runway Growth Finance (RWAY) to Underperform from Neutral and cut its price target to $5.50 from $9, citing ongoing earnings pressure, higher non-accruals, and declining NAV per share, with expectations of further dividend reset. RWAY reported Q1 2026 total investment income of $29.5M and net investment income of $10.6M; two loans moved to nonaccrual.

yahoo.com3 min
OCT 24
$MRNAHigh

Moderna's melanoma vaccine succeeds in major trial. So why did its stock plunge?

Moderna and Merck's experimental melanoma vaccine, combined with Keytruda, reduced recurrence or death risk by 42% in a Phase 3 trial. Despite positive results, Moderna's shares fell 18%, likely due to high investor expectations. The vaccine is personalized using mRNA technology, targeting unique tumor mutations. Trial data showed 82.2% of patients treated with the vaccine and Keytruda were alive without recurrence after two years, compared to 70% with Keytruda alone.

ynetnews.com2 min